Ixempra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic or locally advanced breast cancer after at least two other therapies have not worked. Ixempra may be also referred to by its drug name, ixabepilone.
Ixempra is an epothilone chemotherapy. Ixempra is believed to work by interfering with cancer cells’ ability to divide.
How do I take it?
Prescribing information states that Ixempra is administered as an intravenous infusion every three weeks.
Ixempra comes in the form of an injectable suspension.
The FDA-approved label for Ixempra lists common side effects including injection site reactions (such as pain, redness, or swelling), weakness, tiredness, muscle or joint pain, nausea and vomiting, stomach pain, diarrhea, constipation, loss of appetite, hair loss, and problems with the palms or soles of the feet (such as swelling, pain, or blisters).
Rare but serious side effects listed for Ixempra include hypersensitivity reactions (severe immune reactions to the infusion), nerve problems, severe low blood counts, fetal harm in pregnant women, impaired liver function, heart problems, and cognitive impairment.
For more details about this treatment, visit:
Ixempra — RxList
Ixempra — BreastCancer.org